Pharmacogenomics
短名 | |
Journal Impact | 1.85 |
国际分区 | PHARMACOLOGY & PHARMACY(Q3) |
期刊索引 | SCI Q4中科院 4 区 |
ISSN | 1462-2416, 1744-8042 |
h-index | 100 |
国内分区 | 医学(4区)医学药学(4区) |
PHARMACOGENOMICS (ISSN 1462-2416) 是一份同行评审期刊,提供密切参与这一快速发展领域的研究人员和决策者的评论和报告。主要目标是为社区提供重要资源,以了解这一激动人心的领域所有领域的最新发展。药物基因组学是评论和分析的主要来源,为您带来来自该领域的企业和学术意见领袖的最高质量的专家分析。
期刊主页投稿网址涉及主题 | 生物医学遗传学化学生物化学基因内科学药理学基因型生物信息学心理学病理药物遗传学精神科内分泌学药物基因组学物理有机化学计算生物学 |
出版信息 | 出版商: Taylor and Francis Ltd.,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 2000,原创研究文献占比: 75.34%,自引率:10.50%, Gold OA占比: 11.16% |
平均审稿周期 | 网友分享经验:偏慢,4-8周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury
2024-9-12
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel
2024-9-11
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review
2024-9-4
It is time for educators to act: pharmacogenomics education and its implementation into clinical practice
2024-9-4
Meta-analysis revisiting the influence of <i>UGT1A1*28</i> and <i>UGT1A1*6</i> on irinotecan safety in colorectal cancer patients
2024-8-22
Update on the PriME-PGx initiative: evolution of pharmacogenetics in daily clinical practice
2024-8-8
Implementing pharmacogenomic testing in Australian general practice: an exploratory qualitative study
2024-8-7
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review
2024-8-7
Potential association of <i>SULT2A1</i> and <i>ABCG2</i> variant alleles with increased risk for palbociclib toxicity
2024-8-2
Impact of IL-6 and IL-10 genotypes on tacrolimus dose requirements in kidney transplant recipients: Monte Carlo analysis
2024-7-29
Correlation of <i>ACE</i> insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients
2024-7-29
Rapid point of care testing: the next frontier in pharmacogenomics
2024-7-23
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention
2024-6-6
A critical review of RAF inhibitors in BRAF-mutated glioma treatment
2024-6-3
Impact of <i>CYP2D6</i> and <i>ADRB1</i> polymorphisms on heart rate of post-PCI patients treated with metoprolol
2024-5-31
Screening and analysis of single nucleotide polymorphism in the 3′-UTR microRNA target regions and its implications for lung tumorigenesis
2024-5-30
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma
2024-5-22
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review
2024-5-17
Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation
2024-5-15
Polymorphism of <i>CYP3A4*18</i> is associated with anti-tuberculosis drug-induced hepatotoxicity
2024-5-13
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma
2024-5-13
Erratum
2024-5-9
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities
2024-3-1
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations
2024-3-1
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada
2024-3-1
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization
2024-3-1
Ethnic differences in pharmacogenomic variants: a south Asian perspective
2024-3-1
The genomic landscape of <i>CYP2D6</i> variation in the Indian population
2024-3-1
<i>MIR27A</i> rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of <i>DPYD</i> variations
2024-2-14
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration
2024-2-1
Targeting RET mutation in medullary thyroid cancer
2024-2-1
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study
2024-2-1
<i>PIK3CA</i> testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024-2-1
Association between <i>CYP3A4</i>, <i>CYP3A5</i> and <i>ABCB1</i> genotype and tacrolimus treatment outcomes among allogeneic HSCT patients
2024-1-1
Antiplatelet Therapy Guided by <i>CYP2C19</i> Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions
2024-1-1
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications
2024-1-1
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence
2024-1-1
Psychiatric Level 1A evidence pharmacogenomics in a Brazilian admixed cohort and global populations
2024-1-1
Update on <i>HLA-B*15:02</i> allele associated with adverse drug reactions
2024-1-1
Relevance of <i>NAT2</i> genotype and clinical factors to risk for antituberculosis drug-induced liver injury
2023-12-22
Epigenetic regulation of drug metabolism in aging: utilizing epigenetics to optimize geriatric pharmacotherapy
2023-12-21
Overview of the year 2023 at <i>Pharmacogenomics</i>
2023-12-19
<i>SLCO1B1</i> variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis
2023-12-1
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives
2023-11-1
Characterization of <i>CYP2C19</i> pharmacogenetic variation in African populations and comparison with other global populations
2023-11-1
Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation
2023-11-1
Clinical pharmacology and pharmacogenomics for implementation of personalized medicine
2023-11-1
Towards more accurate pharmacogenomic variant effect predictions
2023-10-17
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka
2023-10-1
Pharmacogenomics of Chloroquine and Hydroxychloroquine: Current Evidence and Future Implications
2023-10-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远